Vaccination in Individuals with Multiple Sclerosis – Part I
Yükleniyor...
Dosyalar
Tarih
2023
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Turkish Neurosurgical Society
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
Multiple sclerosis (MS) is an autoimmune and demyelinating disease of the central nervous system. It is a chronic disease, and in the evaluation of all other health and vital processes, decisions should be made by considering the disease process and the drugs used by the patient. Since vaccination can be performed at every stage of life, from childhood to adulthood, immune system activity, except where it is characteristic of the vaccine, should be reviewed in patients with MS. In this review, the applications of different vaccines in individuals with MS are discussed in two separate sections. © 2023 by Turkish Neurological Society Turkish Journal of Neurology published by Galenos Publishing House.
Açıklama
Anahtar Kelimeler
Multiple sclerosis; safety; vaccination, alemtuzumab; azathioprine; BCG vaccine; cyclophosphamide; dimethyl fumarate; diphtheria pertussis tetanus vaccine; diphtheria tetanus vaccine; fingolimod; glatiramer; hepatitis A vaccine; hepatitis B vaccine; influenza vaccine; measles mumps rubella vaccine; myelin basic protein; natalizumab; ocrelizumab; ofatumumab; ozanimod; rabies vaccine; rituximab; teriflunomide; tetanus toxoid; anaphylaxis; antibody response; apoptosis; asthma; bacteremia; bacterial arthritis; bone marrow transplantation; cardiovascular disease; chronic fatigue syndrome; chronic kidney failure; fatigue; headache; hemodialysis; Hepadnaviridae; hepatitis B; human; immune response; immune system; immunity; immunization; immunogenicity; immunosuppressive treatment; leprosy; mastoiditis; multiple sclerosis; myalgia; obesity; osteomyelitis; pneumococcal infection; post exposure prophylaxis; recombinant DNA technology; Review; Streptococcus pneumoniae; thrombocytopenia; tuberculosis; urticaria; vaccination; viremia
